Open-minded to open innovation and precompetitive collaboration

Review

. 2010 May;87(5):511-5.

doi: 10.1038/clpt.2010.39.

Review

J A Wagner. Clin Pharmacol Ther. 2010 May.

. 2010 May;87(5):511-5.

doi: 10.1038/clpt.2010.39.

No abstract available

Similar articles

Arguments against precompetitive collaboration.
Vargas G, Boutouyrie B, Ostrowitzki S, Santarelli L. Vargas G, et al. Clin Pharmacol Ther. 2010 May;87(5):527-9. doi: 10.1038/clpt.2010.30. Clin Pharmacol Ther. 2010. PMID: 20407456 Review. No abstract available.
The Biomarkers Consortium: practice and pitfalls of open-source precompetitive collaboration.
Wagner JA, Prince M, Wright EC, Ennis MM, Kochan J, Nunez DJ, Schneider B, Wang MD, Chen Y, Ghosh S, Musser BJ, Vassileva MT. Wagner JA, et al. Clin Pharmacol Ther. 2010 May;87(5):539-42. doi: 10.1038/clpt.2009.227. Clin Pharmacol Ther. 2010. PMID: 20407460 Review.
How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development.
Perakslis ED, Van Dam J, Szalma S. Perakslis ED, et al. Clin Pharmacol Ther. 2010 May;87(5):614-6. doi: 10.1038/clpt.2010.21. Epub 2010 Apr 7. Clin Pharmacol Ther. 2010. PMID: 20376001 Review. No abstract available.
The Critical Path Institute's approach to precompetitive sharing and advancing regulatory science.
Woosley RL, Myers RT, Goodsaid F. Woosley RL, et al. Clin Pharmacol Ther. 2010 May;87(5):530-3. doi: 10.1038/clpt.2010.27. Clin Pharmacol Ther. 2010. PMID: 20407457 Review.
Can open-source drug R&D repower pharmaceutical innovation?
Munos B. Munos B. Clin Pharmacol Ther. 2010 May;87(5):534-6. doi: 10.1038/clpt.2010.26. Clin Pharmacol Ther. 2010. PMID: 20407458 Review.

Drug discovery in paediatric oncology: roadblocks to progress.
Adamson PC, Houghton PJ, Perilongo G, Pritchard-Jones K. Adamson PC, et al. Nat Rev Clin Oncol. 2014 Dec;11(12):732-9. doi: 10.1038/nrclinonc.2014.149. Epub 2014 Sep 16. Nat Rev Clin Oncol. 2014. PMID: 25223555 Free PMC article. Review.